Onychomysosis
☆ AI Dermatology — Free Service
Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
Ẹ̀kànná ika ẹsẹ kan tí ó kan Onychomycosis
Ẹni tí ó ní àrùn eékànná fún ọ̀sẹ̀ mẹ́wàá, ń lo oogun ẹnu terbinafine. Ṣe àkíyèsí àwọn àkúnya ilera tó lè hàn lẹ́yìn ìtẹ̀síwájú àrùn eékànná.
relevance score : -100.0%
ReferencesAwọn antifungal eto jẹ itọju ti o munadoko julọ. Itupalẹ meta fihan awọn oṣuwọn imularada mycotic gẹgẹ bi atẹle: terbinafine = 76%, itraconazole with pulse dosing = 63%, itraconazole with continuous dosing = 59%, fluconazole = 48% . Yiyọkuro eekanna concomitant siwaju sii mu awọn oṣuwọn imularada pọ si. Itọju ailera pẹlu ciclopirox ko munadoko; o ni oṣuwọn ikuna ti o ju 60% lọ.
Systemic antifungals are the most effective treatment. Meta-analyses shows mycotic cure rates as follows: terbinafine = 76%, itraconazole with pulse dosing = 63%, itraconazole with continuous dosing = 59%, fluconazole =48%. Concomitant nail debridement further increases cure rates. Topical therapy with ciclopirox is less effective; it has a failure rate exceeding 60%.
Systemic antifungals are the most effective treatment. Meta-analyses shows mycotic cure rates as follows: terbinafine = 76%, itraconazole with pulse dosing = 63%, itraconazole with continuous dosing = 59%, fluconazole =48%. Concomitant nail debridement further increases cure rates. Topical therapy with ciclopirox is less effective; it has a failure rate exceeding 60%.
Onychomycosis jẹ akoran olu ti o kan eekanna. Nigbati o ba ṣẹlẹ nipasẹ awọn dermatophytes, a pe e ni tinea unguium. Onychomycosis pẹlu awọn akoran ti a fa nipasẹ dermatophytes, iwukara, ati m. Iṣoro eekanna ti ko jẹ abajade akoran olu ni a mọ si nail dystrophy. Botilẹjẹpe o le kan eekanna ika ati eekanna ẹsẹ, onychomycosis toenail jẹ wọpọ julọ. Nkan yii yoo jiroro lori ọpọlọpọ awọn ẹya ti onychomycosis ika ẹsẹ, gẹgẹ bi ipa rẹ, awọn iru itọju, awọn ipele, iwadii aisan, ati itọju. Bó tilẹ̀ jẹ́ pé kò ní í dákẹ́ ààyè, onychomycosis lè yọrí sí àwọn àìlera tó ṣe pàtàkì bí cellulitis, sepsis, ikolu egungun, ibajẹ ara, àti isonu eekanna.
Onychomycosis is a fungal infection of the nail unit. When dermatophytes cause onychomycosis, this condition is called tinea unguium. The term onychomycosis encompasses the dermatophytes, yeasts, and saprophytic mold infections. An abnormal nail not caused by a fungal infection is a dystrophic nail. Onychomycosis can infect both fingernails and toenails, but onychomycosis of the toenail is much more prevalent. Discussed in detail in this activity are all evolving facets of the topic, including disease burden, clinical types, staging, diagnosis, and management of toenail onychomycosis. While non-life-threatening, onychomycosis can lead to severe complications such as cellulitis, sepsis, osteomyelitis, tissue damage, and nail loss.
Onychomycosis is a fungal infection of the nail unit. When dermatophytes cause onychomycosis, this condition is called tinea unguium. The term onychomycosis encompasses the dermatophytes, yeasts, and saprophytic mold infections. An abnormal nail not caused by a fungal infection is a dystrophic nail. Onychomycosis can infect both fingernails and toenails, but onychomycosis of the toenail is much more prevalent. Discussed in detail in this activity are all evolving facets of the topic, including disease burden, clinical types, staging, diagnosis, and management of toenail onychomycosis. While non-life-threatening, onychomycosis can lead to severe complications such as cellulitis, sepsis, osteomyelitis, tissue damage, and nail loss.
Terbinafine jẹ́ oogun kan tí ó ń koju àwọn àkóràn olú nípa didi squalene epoxidase. Ó munadoko lòdì sí ọ̀pọ̀ irú àìlera ara, ó sì ti fọwọ́sí fún ìtọ́jú fungus eekanna nígbà tí a bá mu un ní ẹnu. Bí ó tilẹ̀ jẹ́ pé ọ̀pọ̀ àkúnya bíi efori àti àwọn ìṣòro inú jẹ́ kékeré, wọ́n sì ń bọ̀ lọ́wọ́ ara wọn, àyípadà nínú itọ́wọ́ (dysgeusia) lè yàtọ̀ láti ìdíwọ̀n díẹ̀ sí àìdá, nígbà míì tí ó lè yọrí sí pípadà àìlera. Àwọn àyípadà itọ́wọ́ tó wúlò jẹ́ tójé, ṣùgbọ́n wọ́n ti wà ní ìrọ̀rùn.
Terbinafine is an antifungal medication that works through the inhibition of squalene epoxidase. It has activity against most dermatophytes, and it has approval for use as an oral therapy for the treatment of onychomycosis. Although most side effects are mild and self-limited, such as headache and gastrointestinal symptoms, taste disturbances (dysgeusia) can range from mild to severe, resulting in weight loss, and have rarely been reported permanent.
Terbinafine is an antifungal medication that works through the inhibition of squalene epoxidase. It has activity against most dermatophytes, and it has approval for use as an oral therapy for the treatment of onychomycosis. Although most side effects are mild and self-limited, such as headache and gastrointestinal symptoms, taste disturbances (dysgeusia) can range from mild to severe, resulting in weight loss, and have rarely been reported permanent.
Onychomycosis jẹ akoran ti o ní ipa lori eekanna. Ní ayíká 90 % ti àwọn akóran eekanna ika ẹsẹ àti 75 % ti àwọn akóran eekanna ika ni a fà nípasẹ̀ elu (Trichophyton mentagrophytes, Trichophyton rubrum). Àwọn ààmì àìsàn ní í ṣe pẹ̀lú iyípadà eekanna, ìpò tó nipọn, ipinya láti ibùsùn àlàfo, àti ìdàgbàsókè tó pọ̀. Itọju máa ń jẹ́ pẹ̀lú àwọn oogun ẹnu bíi terbinafine tàbí itraconazole, nígbà tí àwọn itọju àgbègbè jẹ́ aṣàyàn fún àwọn ọ̀ràn kékeré tàbí tí kò ní ìwọ̀n tó gíga.
Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75% of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis, onycholysis, and onychauxis. Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general, topical monotherapy can be considered for mild to moderate onychomycosis.
Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75% of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis, onycholysis, and onychauxis. Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general, topical monotherapy can be considered for mild to moderate onychomycosis.
#Clotrimazole
#Miconazole
#Terbinafine
#Butenafine [Lotrimin]
#Tolnaftate
○ Itọju Itọju igba pipẹ ní a nílò nigbagbogbo títí tí eekanna ika ẹsẹ tó ní arun yóò fi yọ́ kúrò patapata. #Terbinafine (oral)
#Itraconazole
#Efinaconazole lacquer [Jublia]
#Ciclopirox lacquer